Active Ingredient(s): Eliglustat
FDA Approved: * August 19, 2014
Pharm Company: * GENZYME CORP
Category: Genetic Disorders

Eliglustat, sold under the brand name Cerdelga, is a medication used for the treatment of Gaucher's disease. It was discovered at the University of Michigan, developed by Genzyme Corp, and was approved by the FDA in August 2014.[3] Commonly used as the tartrate salt, the compound is believed to work by inhibition of glucosylceramide synthase.[4][5] According to an article in Journal of the American Medical Association the oral substrate reductio... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Cerdelga 84 mg Oral Capsule
NDC: 58468-0220
Genzyme Corporation